Co financed project
TrackB – Preclinical and clinical development of innovative TrkB antagonist in treatment of nervous system disorders.
UBA – Preclinical and clinical development of the ubiquitin-proteasome system inhibitor as an innovative drug used in cancer treatment.
AMDBP – Development of a production platform for biosimilars based on CHO cells and an innovative expression system and preclinical and clinical development of a biosimilar drug based on a Fab fragment.
GATE – Preclinical and clinical development of an innovative antagonist of GPR40 receptor in type 2 diabetes treatment
NoteSzHD – “New therapy in psychotic disorders and Huntington’s disease with special focus on cognitive deficits” .
CELONKO – “Development of modern biomarkers and development of an innovative FGFR kinases inhibitor”
JAKSON – Selective JAK/ROCK kinases inihibitor in treatment of immune-mediated diseases